Dr. Gaudino oversees the cannabis genetics and scientific research division for Front Range Biosciences. Formerly the President at Steep Hill, the acquisition of Reggie and his team has significantly advanced FRB’s breeding program, resulting in additional unique and advantaged cannabis and hemp varieties. Dr. Gaudino believes that by using science and technology to help customers succeed and increase profits, FRB can build stronger relationships and be a better partner for customers.
Dr. Gaudino has also served as a genetics researcher with 18-years of intellectual property experience in patent writing, management and prosecution in fields as diverse as software and telecommunications to biotechnology and molecular genetics. Research from Dr. Gaudino has been peer reviewed and published, leading to important new discoveries in the cannabis industry. As an internationally recognized leader in the field of cannabis genetics, Dr. Gaudino has served as a patent agent at Sequenom, Inc., managed IP-based acquisitions for the Vortice Research Group, worked at four law firms focused on biotechnology and an advisor to multiple portfolio investment companies.
Dr. Gaudino received his B.S. in Molecular Biology and Ph.D. in Molecular Genetics from the State University of New York at Buffalo and conducted four years of post-doctoral research at Washington University in St. Louis.